Achieve Life Sciences, a company focused on the development and commercialization of therapies to aid in smoking cessation, has appointed Erik Atkisson as its new Chief Legal Officer. Atkisson’s background includes extensive experience in legal and compliance roles, which is expected to be instrumental in supporting Achieve Life Sciences’ strategic objectives.
Atkisson joins the company at a time when regulatory landscapes in the pharmaceutical and biotechnology sectors are increasingly complex. With a robust portfolio that aims to address nicotine addiction, Achieve Life Sciences is poised to benefit from his leadership in navigating these challenges. His role will be critical in ensuring that the company’s innovative solutions meet all necessary legal standards and regulatory requirements. For more detailed information, please see the announcement by Achieve Life Sciences.
Prior to joining Achieve, Atkisson held key positions in other leading biopharmaceutical companies, where he was responsible for overseeing corporate governance, formalizing compliance frameworks, and leading intellectual property initiatives. His appointment is expected to strengthen Achieve’s leadership team as the company continues to advance its clinical programs.
This strategic hiring move demonstrates Achieve Life Sciences’ commitment to fortifying its legal infrastructure to support its mission. With Atkisson onboard, the company seeks to enhance its capability to effectively bring its developments to market, ultimately striving to impact public health positively by reducing dependence on nicotine.